Leukemia & lymphoma
Real-world treatment patterns and characteristics of patients with diffuse large B-cell lymphoma (DLBCL): a retrospective analysis of US commercial and Medicare claims (2017-2024).
Tycel Phillips, Ziqi Zhou, Cynthia Gutierrez, Anran Shao, Marley Boyd, Sina Noshad, Andriana Hohlbauch, Nicholas Liu, Karen Repetny, Michelle Fanale, Betsy Mitchell, E Anne Davis, Renee Gennarelli, John M Burke
Published: 202610.1080/10428194.2025.2604300
Abstract
To understand the recent, evolving treatment landscape for relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL), we retrospectively analyzed US claims data from MarketScan Commercial Claims and Encounters and Medicare databases and Symphony…
Preview only. Read the full abstract at the source